Skip to content
Recall Observatory FDA recall evidence

Drug product

ESTRADIOL CYP/TEST CYP- SS OIL- 2MG/50MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP/TEST CYP -SS OIL- 2MG/25MG/ML (1ML VIAL) INJECTABLE; ESTRADIOL CYP-CS OIL- 5MG/ML (1.25ML VIAL) INJECTABLE; ESTRADIOL CYP-GS OIL- 5MG/ML (1ML VIAL) INJECTABLE ESTRADIOL CYP-SS OIL- 5MG/ML (1.5ML VIAL) INJECTABLE; ESTRADIOL CYP-SS OIL- 5MG/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

D-0206-2023

December 22, 2022

Class II

Product summary

Firm
Pharmacy Innovations
Event
Event 91332
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0206-2023

Official wording

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Code information: t20221109@7 t20221027@6 t20221010@8 t20221116@36 t20221111@45 t20221026@41

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility